These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20332568)

  • 1. The application of artificial neural networks for phenotypic drug resistance prediction: evaluation and comparison with other interpretation systems.
    Pasomsub E; Sukasem C; Sungkanuparph S; Kijsirikul B; Chantratita W
    Jpn J Infect Dis; 2010 Mar; 63(2):87-94. PubMed ID: 20332568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and performance of conventional HIV-1 phenotyping (Antivirogram®) and genotype-based calculated phenotyping assay (virco®TYPE HIV-1) on protease and reverse transcriptase genes to evaluate drug resistance.
    Pattery T; Verlinden Y; De Wolf H; Nauwelaers D; Van Baelen K; Van Houtte M; Mc Kenna P; Villacian J
    Intervirology; 2012; 55(2):138-46. PubMed ID: 22286884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networks.
    Kjaer J; Høj L; Fox Z; Lundgren JD
    HIV Med; 2008 Oct; 9(8):642-52. PubMed ID: 18631257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks.
    Wang D; Larder B
    J Infect Dis; 2003 Sep; 188(5):653-60. PubMed ID: 12934180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of HIV-1 drug susceptibility phenotype from the viral genotype using linear regression modeling.
    Vermeiren H; Van Craenenbroeck E; Alen P; Bacheler L; Picchio G; Lecocq P;
    J Virol Methods; 2007 Oct; 145(1):47-55. PubMed ID: 17574687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay.
    Choi JY; Kwon OK; Choi SY; Park YK; Kim SS
    J Clin Virol; 2011 Jan; 50(1):19-25. PubMed ID: 20970373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for the interpretation of HIV-1 genotypic drug resistance information.
    Vercauteren J; Vandamme AM
    Antiviral Res; 2006 Sep; 71(2-3):335-42. PubMed ID: 16782210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
    Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
    J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy.
    Hanna GJ; D'Aquila RT
    Clin Infect Dis; 2001 Mar; 32(5):774-82. PubMed ID: 11229846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral drug resistance testing.
    Sen S; Tripathy SP; Paranjape RS
    J Postgrad Med; 2006; 52(3):187-93. PubMed ID: 16855319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy.
    Schmidt B; Walter H; Zeitler N; Korn K
    AIDS Rev; 2002; 4(3):148-56. PubMed ID: 12416449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of artificial neural networks to predict virological response to combination HIV therapy.
    Larder B; Wang D; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; Monforte AD; Torti C; Zazzi M; Lane C
    Antivir Ther; 2007; 12(1):15-24. PubMed ID: 17503743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nine resistance interpretation systems for HIV-1 genotyping.
    Stürmer M; Doerr HW; Staszewski S; Preiser W
    Antivir Ther; 2003 Jun; 8(3):239-44. PubMed ID: 12924541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.
    De Luca A; Vendittelli M; Baldini F; Di Giambenedetto S; Trotta MP; Cingolani A; Bacarelli A; Gori C; Perno CF; Antinori A; Ulivi G
    Antivir Ther; 2004 Aug; 9(4):583-93. PubMed ID: 15456090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems.
    De Luca A; Cozzi-Lepri A; Perno CF; Balotta C; Di Giambenedetto S; Poggio A; Pagano G; Tositti G; Piscopo R; Del Forno A; Chiodo F; Magnani G; d'Arminio Monforte A; ;
    Antivir Ther; 2004 Oct; 9(5):743-52. PubMed ID: 15535412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of resistance testing of HIV-1 to the HIV clinical setting in Japan].
    Yamamoto Y
    Nihon Rinsho; 2002 Apr; 60(4):769-74. PubMed ID: 11968786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting response to antiretroviral treatment by machine learning: the EuResist project.
    Zazzi M; Incardona F; Rosen-Zvi M; Prosperi M; Lengauer T; Altmann A; Sonnerborg A; Lavee T; Schülter E; Kaiser R
    Intervirology; 2012; 55(2):123-7. PubMed ID: 22286881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.